This clinical trial aims to further understand hair care product use and knowledge among women of color. Phthalates are a common ingredient in hair care products and is a well-known endocrine disrupting chemical. Endocrine disrupting chemicals from the surrounding environment may influence the risk of breast cancer; especially when women are exposed to endocrine disrupting chemicals while their breast tissue is changing (such as during pregnancy and postpartum). Learning about the different chemicals in hair care products may help participants make informed decisions about which hair care products they use.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04493892.
PRIMARY OBJECTIVE:
I. To reduce use of personal care products that contain endocrine disrupting chemicals among women.
OUTLINE:
Participants attend 1-2 group sessions via Zoom over 1.5-2.5 hours that includes information on the different chemicals found in hair care products. Participants also undergo collection of urine using a urine collection kit at home.
After completion of group sessions, participants are followed up by phone during mid-late third trimester and at 1-month postpartum.
Trial PhaseNo phase specified
Trial Typeprevention
Lead OrganizationNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
Principal InvestigatorJasmine McDonald
